patent/EA-202090176-A1

Predicate	Object
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
filingDate	2018-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate	2020-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	EA-202090176-A1
titleOfInvention	COMPOSITIONS AND METHODS OF APPLICATION 2- (4-CHLOROPHENYL) -N - ((2- (2,6-DIOXOPIPERIDIN-3-IL) -1-OXOISOINDOLIN-5-IL) METHYL) -2,2-DIFLUOROCETAMAMIDE
abstract	The present invention provides compositions and methods for using 2- (4-chlorophenyl) -N - ((2- (2,6-dioxopiperidin-3-yl) -1-oxoisoindolin-5-yl) methyl) -2,2-difluoroacetamide or a stereoisomer thereof, or a mixture of stereoisomers, a pharmaceutically acceptable salt, tautomer, prodrug, solvate, hydrate, cocrystal, clathrate or polymorph.
priorityDate	2018-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432540604 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118647211

Total number of triples: 19.